<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26063222</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>212</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of Dengue.</ArticleTitle><Pagination><StartPage>2011</StartPage><EndPage>2020</EndPage><MedlinePgn>2011-20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiv321</ELocationID><Abstract><AbstractText>Dengue is a mosquito-borne viral disease that afflicts millions of individuals worldwide every year. Infection by any of the 4 dengue virus (DENV) serotypes can result in a spectrum of disease severity. We investigated the impact of variants of interferon-regulated innate immunity genes with a potent antiviral effect on the outcome of DENV infection. We compared the effect of OAS gene family variants on 2 DENV serotypes in cell culture. While both OAS1-p42 and p46 showed antiviral activity against DENV-2, only OAS1-p42 presented anti-DENV-1 activity. Conversely, whereas both OAS3_S381 and R381 variants were able to block DENV-1 infection, the anti-DENV-2 activity observed for OAS3_S381 was largely lost for the R381 variant. By means of an allelic association study of a cohort of 740 patients with dengue, we found a protective effect of OAS3_R381 against shock (odds ratio [OR], 0.37; P &lt; .001). This effect was due to DENV-2 infections (OR, 0.13; P = .007) but was absent for DENV-1, in accordance with the serotype-dependent OAS3 activity found in the functional study. Severe dengue has long been associated with a cytokine storm of unclear origin. This work identifies an early innate immunity process that could lead to the immune overreaction observed in severe dengue and could be triggered by a specific host genotype-pathogen genotype interaction.</AbstractText><CopyrightInformation>&#xa9; The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simon-Loriere</LastName><ForeName>Etienne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit&#xe9; de G&#xe9;n&#xe9;tique Fonctionnelle des Maladies Infectieuses, Department Genome and Genetics Centre National de la Recherche Scientifique, URA3012, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ren-Jye</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of General Medicine, School of Medicine, College of Medicine, Taipei Medical University Department of Primary Care Medicine, Taipei Medical University Hospital, Taipei City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalayanarooj</LastName><ForeName>Sita Mint</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Dengue Hemorrhagic Fever Research Unit Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuansumrit</LastName><ForeName>Ampaiwan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casademont</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Unit&#xe9; de G&#xe9;n&#xe9;tique Fonctionnelle des Maladies Infectieuses, Department Genome and Genetics Centre National de la Recherche Scientifique, URA3012, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shyr-Yi</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of General Medicine, School of Medicine, College of Medicine, Taipei Medical University Department of Primary Care Medicine, Taipei Medical University Hospital, Taipei City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Han-Pang</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Nankang, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lert-Itthiporn</LastName><ForeName>Worachart</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Bioinformatics and Data Management for Research, Department of Research and Development, Faculty of Medicine, Siriraj Hospital Molecular Medicine Graduate Program.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaiyaratana</LastName><ForeName>Wathanee</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Research Center, Faculty of Medicine, Ramathibodi Hospital.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangthawornchaikul</LastName><ForeName>Nattaya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical Biotechnology Research Unit, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Bangkok.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangnararatchakit</LastName><ForeName>Kanchana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasanawathana</LastName><ForeName>Sirijitt</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Department, Khon Kaen Hospital, Ministry of Public Health.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Bi-Lan</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Nankang, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suriyaphol</LastName><ForeName>Prapat</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Bioinformatics and Data Management for Research, Department of Research and Development, Faculty of Medicine, Siriraj Hospital Center for Emerging and Neglected Infectious Diseases.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoksan</LastName><ForeName>Sutee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Vaccine Development, Institute of Science and Technology for Research and Development, Mahidol University, Nakhon Pathom, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malasit</LastName><ForeName>Prida</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dengue Hemorrhagic Fever Research Unit Center for Emerging and Neglected Infectious Diseases Medical Biotechnology Research Unit, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Bangkok.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Despres</LastName><ForeName>Philipe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Interactions Mol&#xe9;culaires Flavivirus-H&#xf4;tes, Department of Virology, Institut Pasteur.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit&#xe9; de G&#xe9;n&#xe9;tique Fonctionnelle des Maladies Infectieuses, Department Genome and Genetics Centre National de la Recherche Scientifique, URA3012, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Nankang, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakuntabhai</LastName><ForeName>Anavaj</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit&#xe9; de G&#xe9;n&#xe9;tique Fonctionnelle des Maladies Infectieuses, Department Genome and Genetics Centre National de la Recherche Scientifique, URA3012, Paris, France Systems Biology of Diseases Unit, Faculty of Science.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C475085">OAS1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.84</RegistryNumber><NameOfSubstance UI="D015088">2',5'-Oligoadenylate Synthetase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.84</RegistryNumber><NameOfSubstance UI="C577439">OAS3 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015088" MajorTopicYN="N">2',5'-Oligoadenylate Synthetase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">genetic susceptibility</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">interferon</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26063222</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiv321</ArticleId><ArticleId IdType="pii">jiv321</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>